Time trends of chronic HBV infection over prior decades – A global analysis

Journal of Hepatology

Volumn 66, Issue 1, 2017, Pages 48-54

  Ott, Jördis J ^a,b   Horn, Johannes ^a   Krause, Gérard ^a,b,c   Mikolajczyk, Rafael T ^a,b,c  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c German Centre for Infection Research   (Germany)

Author keywords

Chronic; Hepatitis B; Hepatitis B virus; Prevalence; Statistics; Time factor

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE;

ARTICLE; CHRONIC HEPATITIS B; COMPARATIVE STUDY; ENDEMIC DISEASE; HEPATITIS B VIRUS; HIGH INCOME COUNTRY; HUMAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; VACCINATION; WORLD HEALTH ORGANIZATION; COMMUNICABLE DISEASE CONTROL; CROSS-SECTIONAL STUDY; GLOBAL HEALTH; ISOLATION AND PURIFICATION; ORGANIZATION AND MANAGEMENT; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; TRENDS; VIROLOGY;

COMMUNICABLE DISEASE CONTROL; CROSS-SECTIONAL STUDIES; GLOBAL HEALTH; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; PREVALENCE;

EID: 85001032981     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.08.013     Document Type: Article

References (28)

1. [1] Ott, J.J., Ullrich, A., Mascarenhas, M., Stevens, G.A., Global cancer incidence and mortality caused by behavior and infection. J Public Health (Oxf) 33 (2011), 223–233.
2. [2] Schweitzer, A., Horn, J., Mikolajczyk, R.T., Krause, G., Ott, J.J., Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386 (2015), 1546–1555.
3. [3] Dowdle, W.R., The principles of disease elimination and eradication. Bull World Health Organ 76 (1998), 22–25.
4. [4] Hinman, A., Eradication of vaccine-preventable diseases. Annu Rev Public Health 20 (1999), 211–229.
5. [5] Genowska, A., Jamiołkowski, J., Rodakowska, E., Fryc, J., Kozela, M., Pająk, A., Changing 14-year trends in the epidemiology of hepatitis B virus infection in rural and urban Central-Eastern European areas. J Viral Hepat 22 (2015), 1061–1067.
6. [6] La Torre, G., Nicolotti, N., de Waure, C., Chiaradia, G., Specchia, M.L., Mannocci, A., et al. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol J, 5, 2008, 84.
7. [7] Pebody, R.G., Ruutu, P., Nohynek, H., Leinikki, P., Changing epidemiology of hepatitis B infection in Finland. Scand J Infect Dis 31 (1999), 251–254.
8. [8] Spada, E., Mele, A., Ciccozzi, M., Tosti, M.E., Bianco, E., Szklo, A., et al. Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis 33 (2001), 778–784.
9. [9] Su, W.J., Liu, C.C., Liu, D.P., Chen, S.F., Huang, J.J., Chan, T.C., et al. Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in Taiwan. J Infect Dis 205 (2012), 757–762.
10. [10] Chen, C.L., Yang, J.Y., Lin, S.F., Sun, C.A., Bai, C.H., You, S.L., et al. Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan. J Hepatol 63 (2015), 354–363.
11. [11] Hong, W.W., Ang, L.W., Cutter, J.L., James, L., Chew, S.K., Goh, K.T., Changing seroprevalence of hepatitis B virus markers of adults in Singapore. Ann Acad Med Singapore 39 (2010), 591–598.
12. [12] Kim, H., Shin, A.R., Chung, H.H., Kim, M.K., Lee, J.S., Shim, J.J., et al. Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med 28 (2013), 413–419.
13. [13] Liang, P., Zu, J., Yin, J., Li, H., Gao, L., Cui, F., et al. The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China, 1992–2006: A mathematical model analysis. J Theor Biol 386 (2015), 115–121.
14. [14] Beasley, R.P., Rocks along the road to the control of HBV and HCC. Ann Epidemiol 19 (2009), 231–234.
15. [15] Beasley, R.P., Hwang, L.Y., Lin, C.C., Chien, C.S., Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 2 (1981), 1129–1133.
16. [16] Edmunds, W.J., Medley, G.F., Nokes, D.J., Hall, A.J., Whittle, H.C., The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci 253 (1993), 197–201.
17. [17] McMahon, B.J., Alward, W.L., Hall, D.B., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151 (1985), 599–603.
18. [18] Edmunds, W.J., Medley, G.F., Nokes, D.J., O‘Callaghan, C.J., Whittle, H.C., Hall, A.J., et al. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect, 1996, 313–325.
19. [19] Stevens, C.E., Beasley, R.P., Tsui, J., Lee, W.C., Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292 (1975), 771–774.
20. [20] Kiire, C.F., The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut 38 (1996), S5–S12.
21. [21] Davis, L.G., Weber, D.J., Lemon, S.M., Horizontal transmission of hepatitis B virus. Lancet 333 (1989), 889–893.
22. [22] WHO, Hepatitis B vaccines. Wkly Epidemiol Rec 2009 (2009), 405–420.
23. [23] WHO 2015. WHO/UNICEF coverage estimates 2014 revision. July 2015. Immunization Vaccines and Biologicals, (IVB), Geneva, World Health Organization. Vaccine-preventable diseases monitoring system. http://www.who.int/gho/immunization/hepatitis/en/, accessed March 2016.
24. [24] Vryheid, R.E., Kane, M.A., Muller, N., Schatz, G.C., Bezabeh, S., Infant and adolescent hepatitis B immunization up to 1999: a global overview. Vaccine 19 (2000), 1026–1037.
25. [25] Al-Faleh, F.Z., Al-Jeffri, M., Ramia, S., Al-Rashed, R., Arif, M., Rezeig, M., et al. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect 38 (1999), 167–170.
26. [26] Chu, J.J., Wörmann, T., Popp, J., Pätzelt, G., Akmatov, M.K., Krämer, A., et al. Changing epidemiology of hepatitis B and migration – a comparison of six Northern and North-Western European countries. Eur J Public Health 23 (2013), 642–647.
27. [27] OECD. World migration in figures: https://www.oecd.org/els/mig/World-Migration-in-Figures.pdf; accessed April 2016.
28. [28] Sharma, S., Carballo, M., Feld, J.J., Janssen, H.L., Immigration and viral hepatitis. J Hepatol 63 (2015), 515–522.